Splenomegaly
Showing 1 - 25 of 707
PREDIGA 2: Spanish Acronym of "Educational and Diagnostic
Not yet recruiting
- Gaucher Disease
- +4 more
- Patient with splenomegaly or splenectomy
-
Barcelona, SpainHospital Vall d'Hebron
Dec 13, 2022
Splenomegaly; Congestive, Chronic, Panhematopenia; Splenic, Portal Hypertension Trial in Stockholm (Microwave ablation)
Recruiting
- Splenomegaly; Congestive, Chronic
- +2 more
- Microwave ablation
-
Stockholm, SwedenKarolinska University Hospital
Dec 30, 2021
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of
Recruiting
- BCR-JAK2 Fusion Protein Expression
- +11 more
-
Palo Alto, California
- +3 more
Oct 5, 2022
Pediatric Patients With Unexplained Enlarged Spleen
Recruiting
- Gaucher Disease, Splenomegaly
- Acid SphingoMyelinase Deficiency
-
Amiens, France
- +39 more
Aug 19, 2022
DF-003 in ex Vivo Assays Using Peripheral Blood Mononuclear Cell
Recruiting
- Unrecognized Condition
- Adult subjects with ROSAH syndrome
-
Lyon, Rhône-Alpes, FranceHôpital Nord Croix Rousse
Sep 9, 2022
Cholecystitis, Perforated Duodenal Ulcer, Diaphragmatic Hernia Trial in Rawalpindi (Volume-oriented incentive spirometry,
Completed
- Cholecystitis
- +8 more
- Volume-oriented incentive spirometry
- Flow-oriented incentive spirometry
-
Rawalpindi, Punjab, PakistanRailway General hospital
Oct 19, 2021
Liver Cirrhosis, Esophageal and Gastric Varices, Hypersplenism Trial in Jinan (Endoscopic therapy+ beta blockers, Endoscopic
Enrolling by invitation
- Liver Cirrhosis
- +2 more
- Endoscopic therapy+ beta blockers
- +5 more
-
Jinan, Shandong, ChinaQilu Hospital , Shandong University
Feb 14, 2022
Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1
Active, not recruiting
- Ann Arbor Stage II Grade 1 Follicular Lymphoma
- +12 more
- Lenalidomide
- Obinutuzumab
-
Houston, TexasM D Anderson Cancer Center
Feb 18, 2022
Biomarker for Farber Disease (BioFarber)
Active, not recruiting
- Farber's Lipogranulomatosis
- +3 more
-
Cairo, Egypt
- +2 more
May 17, 2021
Biomarker for Sly Disease (MPS VII) (BioSly)
Active, not recruiting
- Developmental Delay
- +3 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)
Active, not recruiting
- Hepato-splenomegaly
- +3 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Biomarker for Pompe Disease (BioPompe)
Active, not recruiting
- Cardiac Diseases
- +6 more
-
Rostock, Germany
- +3 more
May 12, 2021
Point-of-Care Ultrasound in Diagnosis of Acute Infectious
Terminated
- Infectious Mononucleosis
- Splenomegaly
- Point-of-care ultrasound
-
Montreal, Quebec, Canada
- +1 more
Oct 4, 2020
Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)
Terminated
- Leukemia
- +3 more
- Rigosertib
- Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 5, 2020
Acid Sphingomyelinase Deficiency Disease and Gaucher Disease in
Recruiting
- Gaucher Disease
- Acid SphingoMyelinase Deficiency
-
Ponferrada, León, Spain
- +11 more
Aug 8, 2023
Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)
Not yet recruiting
- Metastatic Pancreatic Cancer
- nanoliposomal irinotecan
- spleen irradiation
- (no location specified)
May 8, 2022
Chronic Portal Vein Thrombosis in Children
Not yet recruiting
- Portal Vein Thrombosis
- endoscopy
- (no location specified)
Nov 3, 2023
Spleen; Fibrosis Trial in Rotterdam, Cluj-Napoca, Madrid (FibroScan examination (S), FibroScan examination (M), FibroScan
Recruiting
- Spleen; Fibrosis
- FibroScan examination (S)
- +3 more
-
Rotterdam, Netherlands
- +3 more
Aug 5, 2022
Congenital Cytomegalovirus Infection Trial in Nancy
Completed
- Congenital Cytomegalovirus Infection
-
Nancy, FranceMaternity Hospital CHRU
Feb 22, 2023
Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis
Terminated
- Hepatomegaly
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 23, 2019
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Hepatic Cirrhosis, Portal Hypertension Trial in Jinan (Endoscopic therapy+ beta blockers, Endoscopic therapy+ PSE+beta blockers,
Completed
- Hepatic Cirrhosis
- Portal Hypertension
- Endoscopic therapy+ beta blockers
- +6 more
-
Jinan, Shandong, ChinaDepartment of Gastroenterology,Qilu Hospital,Shandong University
Sep 8, 2021
Myelofibrosis Trial in France (Clonal architecture determination)
Not yet recruiting
- Myelofibrosis
- Clonal architecture determination
-
Angers, France
- +6 more
Jan 24, 2023
Clinical Evident Portal Hypertension on HCC With TACE
Not yet recruiting
- Hepatocellular Carcinoma
- Portal Hypertension
- TACE ± Systemic therapy
-
Nanjing, China
- +1 more
Jan 19, 2023
Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden
Recruiting
- Myeloproliferative Neoplasm
- +3 more
- CALR allele burden quantification
-
Angers, FranceCHU Angers
Nov 2, 2022